Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study
Background:
Assessing the mortality impact of the 2009 influenza A H1N1 virus (H1N1pdm09) is essential for optimizing public health responses to future pandemics. The World Health Organization reported 18,631 laboratory-confirmed pandemic deaths, but the total pandemic mortality burden was substantially higher. We estimated the 2009 pandemic mortality burden through statistical modeling of mortality data from multiple countries.
Methods and Findings:
We obtained weekly virology and underlying cause-of-death mortality time series for 2005–2009 for 20 countries covering ∼35% of the world population. We applied a multivariate linear regression model to estimate pandemic respiratory mortality in each collaborating country. We then used these results plus ten country indicators in a multiple imputation model to project the mortality burden in all world countries. Between 123,000 and 203,000 pandemic respiratory deaths were estimated globally for the last 9 mo of 2009. The majority (62%–85%) were attributed to persons under 65 y of age. We observed a striking regional heterogeneity, with almost 20-fold higher mortality in some countries in the Americas than in Europe. The model attributed 148,000–249,000 respiratory deaths to influenza in an average pre-pandemic season, with only 19% in persons <65 y. Limitations include lack of representation of low-income countries among single-country estimates and an inability to study subsequent pandemic waves (2010–2012).
Conclusions:
We estimate that 2009 global pandemic respiratory mortality was ∼10-fold higher than the World Health Organization's laboratory-confirmed mortality count. Although the pandemic mortality estimate was similar in magnitude to that of seasonal influenza, a marked shift toward mortality among persons <65 y of age occurred, so that many more life-years were lost. The burden varied greatly among countries, corroborating early reports of far greater pandemic severity in the Americas than in Australia, New Zealand, and Europe. A collaborative network to collect and analyze mortality and hospitalization surveillance data is needed to rapidly establish the severity of future pandemics.
Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study. PLoS Med 10(11): e32767. doi:10.1371/journal.pmed.1001558
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001558
Souhrn
Background:
Assessing the mortality impact of the 2009 influenza A H1N1 virus (H1N1pdm09) is essential for optimizing public health responses to future pandemics. The World Health Organization reported 18,631 laboratory-confirmed pandemic deaths, but the total pandemic mortality burden was substantially higher. We estimated the 2009 pandemic mortality burden through statistical modeling of mortality data from multiple countries.
Methods and Findings:
We obtained weekly virology and underlying cause-of-death mortality time series for 2005–2009 for 20 countries covering ∼35% of the world population. We applied a multivariate linear regression model to estimate pandemic respiratory mortality in each collaborating country. We then used these results plus ten country indicators in a multiple imputation model to project the mortality burden in all world countries. Between 123,000 and 203,000 pandemic respiratory deaths were estimated globally for the last 9 mo of 2009. The majority (62%–85%) were attributed to persons under 65 y of age. We observed a striking regional heterogeneity, with almost 20-fold higher mortality in some countries in the Americas than in Europe. The model attributed 148,000–249,000 respiratory deaths to influenza in an average pre-pandemic season, with only 19% in persons <65 y. Limitations include lack of representation of low-income countries among single-country estimates and an inability to study subsequent pandemic waves (2010–2012).
Conclusions:
We estimate that 2009 global pandemic respiratory mortality was ∼10-fold higher than the World Health Organization's laboratory-confirmed mortality count. Although the pandemic mortality estimate was similar in magnitude to that of seasonal influenza, a marked shift toward mortality among persons <65 y of age occurred, so that many more life-years were lost. The burden varied greatly among countries, corroborating early reports of far greater pandemic severity in the Americas than in Australia, New Zealand, and Europe. A collaborative network to collect and analyze mortality and hospitalization surveillance data is needed to rapidly establish the severity of future pandemics.
Please see later in the article for the Editors' Summary
Zdroje
1. World Health Organization (2010) Pandemic (H1N1) 2009—update 112. Available: http://www.who.int/csr/don/2010_08_06/en/index.html. Accessed 12 October 2012.
2. EnserinkM, CohenJ (2009) Virus of the year. The novel H1N1 influenza. Science 326: 1607.
3. FlynnP (2010) The handling of the H1N1 pandemic: more transparency needed. Council of Europe Parliamentary Assembly
4. SimonsenL, ClarkeMJ, SchonbergerLB, ArdenNH, CoxNJ, et al. (1998) Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 178: 53–60.
5. ViboudC, GraisRF, LafontBA, MillerMA, SimonsenL (2005) Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic. J Infect Dis 192: 233–248.
6. MillerMA, ViboudC, BalinskaM, SimonsenL (2009) The signature features of influenza pandemics—implications for policy. N Engl J Med 360: 2595–2598.
7. MillerMA, ViboudC, OlsonDR, GraisRF, RabaaMA, et al. (2008) Prioritization of influenza pandemic vaccination to minimize years of life lost. J Infect Dis 198: 305–311.
8. ViboudC, MillerM, OlsonD, OsterholmM, SimonsenL (2010) Preliminary estimates of mortality and years of life lost associated with the 2009 A/H1N1 pandemic in the US and comparison with past influenza seasons. PLoS Curr 2: RRN1153 doi:10.1371/currents.RRN1153
9. CharuV, ChowellG, Palacio MejiaLS, Echevarria-ZunoS, Borja-AburtoVH, et al. (2011) Mortality burden of the A/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza. Clin Infect Dis 53: 985–993.
10. LemaitreM, CarratF, ReyG, MillerM, SimonsenL, et al. (2012) Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS ONE 7: e45051 doi:10.1371/journal.pone.0045051
11. MuscatelloDJ, CretikosMA, MacintyreCR (2010) All-cause mortality during first wave of pandemic (H1N1) 2009, New South Wales, Australia, 2009. Emerg Infect Dis 16: 1396–1402.
12. Schuck-PaimC, ViboudC, SimonsenL, MillerMA, MouraFE, et al. (2012) Were equatorial regions less affected by the 2009 influenza pandemic? The Brazilian experience. PLoS ONE 7: e41918 doi:10.1371/journal.pone.0041918
13. WijngaardCC, AstenL, KoopmansMP, PeltW, NagelkerkeNJ, et al. (2012) Comparing pandemic to seasonal influenza mortality: moderate impact overall but high mortality in young children. PLoS ONE 7: e31197 doi:10.1371/journal.pone.0031197
14. YuH, FengL, ViboudCG, ShayDK, JiangY, et al. (2013) Regional variation in mortality impact of the 2009 A(H1N1) influenza pandemic in China. Influenza Other Respi Viruses E-pub ahead of print. doi: 10.1111/irv.12121
15. LiangW, FengL, XuC, XiangN, ZhangY, et al. (2012) Response to the first wave of pandemic (H1N1) 2009: experiences and lessons learnt from China. Public Health 126: 427–436.
16. Van KerkhoveMD, VandemaeleKA, ShindeV, Jaramillo-GutierrezG, KoukounariA, et al. (2011) Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 8: e1001053 doi:10.1371/journal.pmed.1001053
17. McCallumL (2010) Epidemiological characteristics of the influenza A(H1N1) 2009 pandemic in the Western Pacific Region. Western Pac Surveill Response J 1: 5–11.
18. MurrayCJ, LopezAD, ChinB, FeehanD, HillKH (2006) Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918–20 pandemic: a quantitative analysis. Lancet 368: 2211–2218.
19. DawoodFS, IulianoAD, ReedC, MeltzerMI, ShayDK, et al. (2012) Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 12: 687–695.
20. World Health Organization (2013) FluNet [database]. Available: http://www.who.int/influenza/gisrs_laboratory/flunet/en/. Accessed 22 October 2013.
21. World Health Organization (2011) Summary of WHO technical consultation: H1N1pdm mortality estimates. Available: http://www.who.int/influenza/surveillance_monitoring/updates/MortalityEstimates/en/. Accessed 26 October 2013.
22. PitmanRJ, MelegaroA, GelbD, SiddiquiMR, GayNJ, et al. (2007) Assessing the burden of influenza and other respiratory infections in England and Wales. J Infect 54: 530–538.
23. ThompsonWW, ShayDK, WeintraubE, BrammerL, CoxN, et al. (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289: 179–186.
24. ThompsonWW, WeintraubE, DhankharP, ChengPY, BrammerL, et al. (2009) Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respi Viruses 3: 37–49.
25. ZhouH, ThompsonWW, ViboudCG, RingholzCM, ChengPY, et al. (2012) Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008. Clin Infect Dis 54: 1427–1436.
26. Buuren S (2012) Flexible imputation of missing data. Boca Raton (Florida): CRC Press.
27. World Health Organization (2013) Global health observatory data repository [database]. Available: http://apps.who.int/gho/data/view.main. Accessed 11 November 2011.
28. World Bank (2013) Data: indicators [database]. Available: http://data.worldbank.org/indicator/. Accessed 1 November 2011.
29. United Nations Statistics Division (2013) UNdata: explorer [database]. Available: http://data.un.org/Explorer.aspx?d=POP. Accessed 1 November 2011.
30. Thematic Mapping (2013) World borders database [database]. Available: http://thematicmapping.org/downloads/world_borders.php. Accessed 1 November 2011.
31. Raudenbush SW, Bryk AS (2002) Hierarchical linear models, applications and data analysis methods. Thousand Oaks (California): Sage Publications.
32. GoldsteinH, SpiegelhalterDJ (1996) League tables and their limitations: statistical issues in comparisons of institutional performance. J R Stat Soc Ser A Stat Soc 159: 385–443.
33. NormandS, GlickmanM, GastonisCA (1997) Statistical methods for profiling providers of medical care: issues and applications. J Am Stat Assoc 92: 803–814.
34. HonakerJ, KingG, BlackwellM (2011) Amelia II: a program for missing data. J Stat Softw 45: 1–47 Available: http://www.jstatsoft.org/v45/i07/. Accessed 29 October 2013.
35. Hasbash J, Charlton C, Browne WJ, Healy M, Cameron B (2009) MLwiN, version 2.1. Bristol: Centre for Multilevel Modelling, University of Bristol.
36. CookDA, BeckmanTJ (2006) Current concepts in validity and reliability for psychometric instruments: theory and application. Am J Med 119: 166.e7–16.
37. World Health Organization (2005) WHO global influenza preparedness plan: the role of WHO and recommendations for national measures before and during pandemics. WHO/CDS/CSR/GIP/20055. Geneva: World Health Organization.
38. AndreasenV, ViboudC, SimonsenL (2008) Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies. J Infect Dis 197: 270–278.
39. OlsonDR, SimonsenL, EdelsonPJ, MorseSS (2005) Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City. Proc Natl Acad Sci U S A 102: 11059–11063.
40. ChowellG, BertozziSM, ColcheroMA, Lopez-GatellH, Alpuche-ArandaC, et al. (2009) Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 361: 674–679.
41. FraserC, DonnellyCA, CauchemezS, HanageWP, Van KerkhoveMD, et al. (2009) Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324: 1557–1561.
42. BakerM, KellyH, WilsonN (2009) Pandemic H1N1 influenza lessons from the southern hemisphere. Euro Surveill 14.
43. BorseRH, ShresthaSS, FioreAE, AtkinsCY, SingletonJA, et al. (2013) Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009–2010. Emerg Infect Dis 19: 439–448.
44. GaugerPC, VincentAL, LovingCL, LagerKM, JankeBH, et al. (2011) Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus. Vaccine 29: 2712–2719.
45. HomairaN, LubySP, AlamgirAS, IslamK, PaulR, et al. (2012) Influenza-associated mortality in 2009 in four sentinel sites in Bangladesh. Bull World Health Organ 90: 272–278.
46. KatzMA, LeboE, EmukuleG, NjugunaHN, AuraB, et al. (2012) Epidemiology, seasonality, and burden of influenza and influenza-like illness in urban and rural Kenya, 2007–2010. J Infect Dis 206 (Suppl 1) S53–S60.
47. PebodyRG, AndrewsN, FlemingDM, McMenaminJ, CottrellS, et al. (2012) Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom. Epidemiol Infect 13: 1–11.
48. ChowellG, Echevarría-ZunoS, ViboudC, SimonsenL, Grajales MunizC, et al. (2012) Recrudescent wave of pandemic A/H1N1 influenza in Mexico, winter 2011–2012: age shift and severity. PLoS Curr 4: RRN1306 doi:10.1371/currents.RRN1306
49. Borja-AburtoVH, ChowellG, ViboudC, SimonsenL, MillerMA, et al. (2012) Epidemiological characterization of a fourth wave of pandemic A/H1N1 influenza in Mexico, winter 2011–2012: age shift and severity. Arch Med Res 43: 563–570.
50. YangL, ChanKP, CowlingBJ, ChiuSS, ChanKH, et al. (2012) Excess mortality associated with the 2009 pandemic of influenza A(H1N1) in Hong Kong. Epidemiol Infect 140: 1542–1550.
51. EuroMOMO (2013) European mortality bulletin, week 23, 2013. Copenhagen: EuroMOMO.
52. WuJT, MaES, LeeCK, ChuDK, HoPL, et al. (2010) The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 51: 1184–1191.
53. SchanzerDL, SchwartzB (2013) Impact of seasonal and pandemic influenza on emergency department visits, 2003–2010, Ontario, Canada. Acad Emerg Med 20: 388–397.
54. ShresthaSS, SwerdlowDL, BorseRH, PrabhuVS, FinelliL, et al. (2011) Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009–April 2010). Clin Infect Dis 52 (Suppl 1) S75–S82.
55. SkowronskiDM, De SerresG, CrowcroftNS, JanjuaNZ, BoulianneN, et al. (2010) Association between the 2008?09 seasonal influenza vaccine and pandemic H1N1 illness during spring?summer 2009: four observational studies from Canada. PLoS Med 7 (4) e1000258doi:10.1371/journal.pmed.1000258
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2013 Číslo 11
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- A Brief Patient-Reported Outcomes Quality of Life (PROQOL) Instrument to Improve Patient Care
- Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010
- From Ideals to Tools: Applying Human Rights to Maternal Health
- Role of DNA Methylation and Epigenetic Silencing of in Endometrial Cancer Development